CONMED (CNMD) Peer Comparison

$44.29

$-1.43 (-3.13%)

As on 30-Oct-2026 16:00EST

Market cap

$1,320 Mln

Revenue (TTM)

$1,370 Mln

P/E Ratio

18.4

P/B Ratio

1.3

Div. Yield

0 %

Edit

	CONMED (CNMD)	Penumbra (PEN)	Avantor (AVTR)	Repligen (RGEN)	Glaukos Corp (GKOS)
Market cap ($ Mln)	1,320	12,682	10,876	11,234	14,302
Revenue ($ Mln)	1,370	1,560	6,636	806	690
Net Profit ($ Mln)	73.43	157.02	337.20	-11.80	-169.80
Net Margin (%)	5.36	10.06	5.08	-1.47	-24.60
RoE (%)	7.07	10.27	5.90	-0.56	-24.46
Price to Earnings	18.38	79.11	32.10	--	--
Price-To-Book	1.29	8.19	1.94	5.37	20.01

Income Statement ($ Mln)

	CONMED (CNMD)	Penumbra (PEN)	Avantor (AVTR)	Repligen (RGEN)	Glaukos Corp (GKOS)
Operating Revenue	1,369.57	1,560.33	6,635.60	805.61	690.33
Cost of Revenue	586.19	499.55	4,539.20	394.34	130.29
Gross Profit	725.38	942.44	2,139.40	347.62	393.22
Operating Expenses	617.54	871.54	1,593.70	392.34	623.34
Operating Profit (EBIT)	165.84	189.25	502.70	18.93	-63.30
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	104.96	207.82	315.50	8.23	-174.52
Provision for Tax	31.53	50.81	-21.70	20.03	-4.72
Profit after Tax (Net Income)	73.43	157.02	337.20	-11.80	-169.80
Minority Interest	0.00	0.00	0.00	0.00	0.00
Consolidated Profit	0.00	47.34	0.00	0.00	0.00

	CONMED (CNMD)	Penumbra (PEN)	Avantor (AVTR)	Repligen (RGEN)	Glaukos Corp (GKOS)
Shareholder's Funds	1,059.92	1,583.51	5,835.90	2,091.74	717.27
Minority Interest	0.00	0.00	0.00	0.00	0.00
Non-Current Liabilities	785.58	207.78	4,425.10	708.99	135.53
Current Liabilities	458.96	233.81	1,369.00	125.69	126.73
Total Liabilities	2,325.75	1,826.52	11,794.70	2,949.70	893.49

	CONMED (CNMD)	Penumbra (PEN)	Avantor (AVTR)	Repligen (RGEN)	Glaukos Corp (GKOS)
Non-Current Assets	1,622.42	648.47	9,037.40	1,684.42	399.88
Current Assets	682.04	1,376.63	2,592.60	1,241.98	579.65
Total Assets	2,325.75	1,826.52	11,794.70	2,949.70	893.49
Total Debt*	815.87	209.39	3,683.80	692.24	101.98
Net Current Assets	0.00	0.00	1,223.60	0.00	452.92

	CONMED (CNMD)	Penumbra (PEN)	Avantor (AVTR)	Repligen (RGEN)	Glaukos Corp (GKOS)
Cash From Operating Activities	170.69	238.66	623.80	117.42	-46.34
Cash Flow from Investing Activities	-20.96	-404.59	-130.50	-298.47	-77.61
Cash from Financing Activities	-135.82	26.53	-409.40	-15.21	11.89
Net Cash Inflow / Outflow	--	--	--	--	--

	CONMED (CNMD)	Penumbra (PEN)	Avantor (AVTR)	Repligen (RGEN)	Glaukos Corp (GKOS)
ROCE (%)	2.52	11.76	-5.43	1.79	-22.53
ROE (%)	7.07	10.27	5.90	-0.56	-24.46
ROA (%)	2.61	5.91	2.57	-0.33	-15.48
EBIT Margin (%)	10.11	13.40	7.39	4.20	-24.51
Net Margin (%)	5.36	10.06	5.08	-1.47	-24.60
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	CONMED (CNMD)	Penumbra (PEN)	Avantor (AVTR)	Repligen (RGEN)	Glaukos Corp (GKOS)
Revenue Growth (%)	1.68	16.98	0.92	13.80	46.94
EBIT Growth (%)	17.22	11.72	106.97	29.47	-106.70
Net Profit Growth (%)	14.61	-4.27	510.22	-779.17	-93.80
EPS Growth (%)	17.16	-4.95	507.22	-910.66	-90.00
Book Value Growth (%)	8.35	15.61	4.89	0.35	-12.58

	CONMED (CNMD)	Penumbra (PEN)	Avantor (AVTR)	Repligen (RGEN)	Glaukos Corp (GKOS)
Price / Earnings	26.77	68.93	-14.68	189.42	-34.59
Price / Book Value	1.29	8.19	1.94	5.37	20.01
Dividend Yield (%)	0.00	0.00	0.00	0.00	0.00
EV/EBITDA	10.00	53.91	15.90	88.63	-114.22
Market Cap ($ Cr)	--	--	--	--	--

	CONMED (CNMD)	Penumbra (PEN)	Avantor (AVTR)	Repligen (RGEN)	Glaukos Corp (GKOS)
Debt to Equity	0.00	0.00	0.63	0.00	0.00
Short term debt to equity ratio	0.17	0.01	0.01	0.01	0.00
Current Ratio	1.49	5.89	1.89	9.88	4.57
Quick Ratio	0.70	3.92	1.27	8.43	4.09
Interest Coverage	4.14	165.16	2.81	1.24	-35.23

	CONMED (CNMD)	Penumbra (PEN)	Avantor (AVTR)	Repligen (RGEN)	Glaukos Corp (GKOS)
Debtors to sales (%)	17.08	12.51	16.92	18.77	21.73
Asset Turnover	0.49	0.59	0.51	0.22	0.63
Receivable days	64.52	46.54	58.79	72.41	60.95
Inventory Days	197.58	331.92	64.13	146.53	193.84
Payable days	55.11	26.16	58.13	29.05	60.19
Cash Conversion Cycle	206.98	352.30	64.79	189.88	194.60

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.